Achieve life sciences president and cmo, dr. cindy jacobs, speaks at fda and nih smoking cessation public meeting

Seattle and vancouver, british columbia, oct. 23, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, announced that dr. cindy jacobs, achieve's president and chief medical officer, presented at the u.s. food and drug administration (fda) and the national institutes of health (nih) joint public meeting on “advancing smoking cessation: fda and nih priorities” held on october 21, 2024.
ACHV Ratings Summary
ACHV Quant Ranking